Living donor liver transplantation (LDLT) represents an alternative to expand the organ pool for adult patients with hepatocellular carcinoma (HCC) and end-stage liver disease. The purpose of this study was to demonstrate our institutional experience using criteria exceeding those of the University of California San Francisco (UCSF).
Department of General, Visceral, and Transplantation Surgery, University Hospital, Essen, Germany; Organ Transplant Unit, Hippocration University Hospital, Thessaloniki, Greece.